ELV logo

Elevance Health (ELV) Accounts receivable

Annual accounts receivable:

$8.01B+$109.00M(+1.38%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ELV annual accounts receivable is $8.01 billion, with the most recent change of +$109.00 million (+1.38%) on December 31, 2024.
  • During the last 3 years, ELV annual accounts receivable has risen by +$2.33 billion (+41.01%).
  • ELV annual accounts receivable is now at all-time high.

Performance

ELV Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVbalance sheet metrics

Quarterly accounts receivable:

$10.36B+$2.35B(+29.31%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ELV quarterly accounts receivable is $10.36 billion, with the most recent change of +$2.35 billion (+29.31%) on March 31, 2025.
  • Over the past year, ELV quarterly accounts receivable has increased by +$1.43 billion (+15.99%).
  • ELV quarterly accounts receivable is now -13.90% below its all-time high of $12.03 billion, reached on March 31, 2023.

Performance

ELV Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

ELV Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.4%+16.0%
3 y3 years+41.0%-8.6%
5 y5 years+59.8%+23.3%

ELV Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+41.0%-13.9%+46.3%
5 y5-yearat high+59.8%-13.9%+96.2%
alltimeall timeat high>+9999.0%-13.9%>+9999.0%

ELV Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$10.36B(+29.3%)
Dec 2024
$8.01B(+1.4%)
$8.01B(+11.1%)
Sep 2024
-
$7.21B(-10.3%)
Jun 2024
-
$8.04B(-10.0%)
Mar 2024
-
$8.93B(+13.0%)
Dec 2023
$7.90B(+11.6%)
$7.90B(+0.2%)
Sep 2023
-
$7.88B(+6.1%)
Jun 2023
-
$7.43B(-38.2%)
Mar 2023
-
$12.03B(+69.9%)
Dec 2022
$7.08B(+24.7%)
$7.08B(-32.9%)
Sep 2022
-
$10.55B(-0.4%)
Jun 2022
-
$10.60B(-6.4%)
Mar 2022
-
$11.33B(+99.4%)
Dec 2021
$5.68B(+7.6%)
$5.68B(-39.3%)
Sep 2021
-
$9.36B(-0.9%)
Jun 2021
-
$9.44B(+54.5%)
Mar 2021
-
$6.11B(+15.8%)
Dec 2020
$5.28B(+5.3%)
$5.28B(-36.6%)
Sep 2020
-
$8.33B(+5.2%)
Jun 2020
-
$7.92B(-5.8%)
Mar 2020
-
$8.40B(+67.5%)
Dec 2019
$5.01B(-25.6%)
$5.01B(+4.9%)
Sep 2019
-
$4.78B(-34.4%)
Jun 2019
-
$7.29B(-3.4%)
Mar 2019
-
$7.54B(+11.8%)
Dec 2018
$6.74B(+9.0%)
$6.74B(-2.9%)
Sep 2018
-
$6.94B(+0.4%)
Jun 2018
-
$6.92B(+10.6%)
Mar 2018
-
$6.26B(+1.1%)
Dec 2017
$6.18B(+5.5%)
$6.18B(+8.7%)
Sep 2017
-
$5.69B(-6.8%)
Jun 2017
-
$6.11B(+5.8%)
Mar 2017
-
$5.77B(-1.5%)
Dec 2016
$5.86B(+27.3%)
$5.86B(+12.4%)
Sep 2016
-
$5.21B(-0.9%)
Jun 2016
-
$5.26B(+5.3%)
Mar 2016
-
$5.00B(+8.6%)
Dec 2015
$4.60B(-4.6%)
$4.60B(+4.6%)
Sep 2015
-
$4.40B(-10.9%)
Jun 2015
-
$4.94B(-0.5%)
Mar 2015
-
$4.96B(+2.9%)
Dec 2014
$4.83B(+21.6%)
$4.83B(+8.7%)
Sep 2014
-
$4.44B(-2.4%)
Jun 2014
-
$4.55B(+2.0%)
Mar 2014
-
$4.46B(+12.3%)
DateAnnualQuarterly
Dec 2013
$3.97B(+7.6%)
$3.97B(-1.1%)
Sep 2013
-
$4.01B(-7.3%)
Jun 2013
-
$4.33B(+5.6%)
Mar 2013
-
$4.10B(+11.2%)
Dec 2012
$3.69B(+8.4%)
$3.69B(+1.1%)
Sep 2012
-
$3.65B(-6.3%)
Jun 2012
-
$3.89B(+4.5%)
Mar 2012
-
$3.72B(+9.4%)
Dec 2011
$3.40B(+11.9%)
$3.40B(+2.8%)
Sep 2011
-
$3.31B(+6.7%)
Jun 2011
-
$3.10B(-6.1%)
Mar 2011
-
$3.30B(+8.6%)
Dec 2010
$3.04B(-7.3%)
$3.04B(-13.1%)
Jun 2010
-
$3.50B(+6.1%)
Mar 2010
-
$3.30B(+0.5%)
Dec 2009
$3.28B(+7.8%)
$3.28B(+0.1%)
Sep 2009
-
$3.28B(-5.3%)
Jun 2009
-
$3.46B(-1.9%)
Mar 2009
-
$3.53B(+15.9%)
Dec 2008
$3.04B(+6.0%)
$3.04B(-6.8%)
Sep 2008
-
$3.27B(+1.9%)
Jun 2008
-
$3.20B(+1.1%)
Mar 2008
-
$3.17B(+10.3%)
Dec 2007
$2.87B(+22.9%)
$2.87B(+2.5%)
Sep 2007
-
$2.80B(+6.6%)
Jun 2007
-
$2.63B(-5.9%)
Mar 2007
-
$2.79B(+19.5%)
Dec 2006
$2.34B(+1.7%)
$2.34B(-49.5%)
Sep 2006
-
$4.63B(+9.8%)
Jun 2006
-
$4.21B(+84.7%)
Mar 2006
-
$2.28B(-0.6%)
Dec 2005
$2.30B(+45.8%)
$2.30B(+30.6%)
Sep 2005
-
$1.76B(+3.2%)
Jun 2005
-
$1.70B(+1.3%)
Mar 2005
-
$1.68B(+6.7%)
Dec 2004
$1.57B(+1958.3%)
$1.57B(+41.1%)
Sep 2004
-
$1.12B(+0.3%)
Jun 2004
-
$1.11B(+1.8%)
Mar 2004
-
$1.09B(+2.6%)
Sep 2003
-
$1.06B(+6.7%)
Jun 2003
-
$997.70M(+10.4%)
Mar 2003
-
$903.80M(+1081.4%)
Dec 2002
$76.50M
$76.50M(-2.9%)
Sep 2002
-
$78.80M(+1.9%)
Jun 2002
-
$77.30M(-0.4%)
Mar 2002
-
$77.60M

FAQ

  • What is Elevance Health annual accounts receivable?
  • What is the all time high annual accounts receivable for Elevance Health?
  • What is Elevance Health annual accounts receivable year-on-year change?
  • What is Elevance Health quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Elevance Health?
  • What is Elevance Health quarterly accounts receivable year-on-year change?

What is Elevance Health annual accounts receivable?

The current annual accounts receivable of ELV is $8.01B

What is the all time high annual accounts receivable for Elevance Health?

Elevance Health all-time high annual accounts receivable is $8.01B

What is Elevance Health annual accounts receivable year-on-year change?

Over the past year, ELV annual accounts receivable has changed by +$109.00M (+1.38%)

What is Elevance Health quarterly accounts receivable?

The current quarterly accounts receivable of ELV is $10.36B

What is the all time high quarterly accounts receivable for Elevance Health?

Elevance Health all-time high quarterly accounts receivable is $12.03B

What is Elevance Health quarterly accounts receivable year-on-year change?

Over the past year, ELV quarterly accounts receivable has changed by +$1.43B (+15.99%)
On this page